Related Experiment Video
Updated: Jul 3, 2026
06:58
Frailty Assessment in an Aging Mouse Model
Published on: September 23, 2025
Validation of prognostic indices using the frailty model.
C Legrand1, L Duchateau, P Janssen
1European Organisation for Research and Treatment of Cancer, 1200, Brussels, Belgium. catherine.legrand@uclouvain.be
Lifetime Data Analysis
|July 12, 2008
Summary
This study introduces a novel method to assess prognostic index generalizability by examining risk group heterogeneity across different clinical centers. The findings highlight the importance of accounting for center-specific variations for accurate patient risk stratification.
Area of Science:
- Biostatistics
- Clinical Epidemiology
- Oncology
Background:
- Prognostic index generalizability is crucial for clinical practice.
- Current validation methods often overlook center-specific variations.
- Heterogeneity in prognostic index performance across centers can limit its utility.
Purpose of the Study:
- To introduce a novel statistical approach for assessing prognostic index generalizability.
- To model and quantify the heterogeneity of prognostic index risk group hazard ratios across different centers.
- To provide methods for investigating and interpreting this heterogeneity in real-world data.
Main Methods:
- Utilized a frailty model incorporating random center effects and random prognostic index by center interactions.
- Employed a Bayesian approach for statistical inference.
- Applied a Laplacian approximation for the marginal posterior distribution of random effects variances.
- Investigated methods to summarize information from the marginal posterior distribution.
Main Results:
- Demonstrated a method to quantify heterogeneity in prognostic index performance across centers.
- Applied the approach to a bladder cancer database.
- Showcased how to interpret center-specific variations in prognostic index effectiveness.
- Identified potential limitations of prognostic indices when heterogeneity is present.
Conclusions:
- The proposed method enhances the assessment of prognostic index generalizability beyond average performance.
- Accounting for center-specific heterogeneity is vital for reliable clinical application of prognostic indices.
- This approach provides valuable insights for developing and validating robust prognostic tools in oncology.
